A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
Clinical trial NCT04781959 · COMPLETED
Trial details
- NCT number
- NCT04781959
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2023-02-23
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.